Myriad Genetics Inc

MYGN NASDAQ Healthcare & Biotech United States US62855J1043
4.14 $
7.25 %

Myriad Genetics Inc is a molecular diagnostics company that develops and commercializes predictive tests for cancer and other hereditary diseases.